Christina Cho

Christina Cho, PhD is an Associate Research Scientist at the Yale School of Medicine, affiliated with the Chen Lab. Her research focuses on cancer biology, particularly the tumor microenvironment (TME), immune evasion mechanisms, and the development of novel immunotherapies. She has expertise in mechanosignaling pathways and type I interferon-mediated processes in cancer progression. Dr. Cho holds a BS from the University of California-Los Angeles (2009), a PhD from Albany Medical College (2017), and completed postdoctoral training at the University of Pennsylvania (2020).

• Education:
• BS, University of California-Los Angeles (2009)
• PhD, Albany Medical College (2017)
• Postdoctoral Associate, University of Pennsylvania (2020)

Her research interests include identifying novel cell surface receptors influencing T cell responses, understanding how dysregulated cholesterol biosynthesis impacts tumor progression, and investigating the role of unfolded fibronectin fibrils in drug resistance. She has pioneered work on immune evasion pathways and biomarkers for checkpoint blockade therapies.

Key Honors:

• Robert E. Leet and Clara Guthrie Patterson Trust Mentored Research Award (2023, 2025)
• iBiology Share Your Research Competition Winner (2021)
• Milstein Travel Award (2018)

Collaborations with Matthew Vesely, Michal Kidacki, and Lieping Chen highlight her work in spatial transcriptomics and immunotherapy. No specific grant or advising roles are explicitly listed in the provided texts, though her research implies significant institutional support. The Chen Lab serves as her primary research hub, focusing on translational oncology and immune mechanisms.